Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 3/20 | 0.55 |
| ▸ | CA5A | P35218 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | FYN | P06241 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CA3 | P07451 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA6 | P23280 | 2/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11762568 | 1.00 | TPMT (0.55) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL15835579 | 0.92 | DHODH (0.48) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL15198825 | 0.90 | CA5A (0.73) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL838335 | 0.90 | TPMT (0.73) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL13790658 | 0.88 | DHODH (0.55) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL22198389 | 0.88 | TPMT (0.44) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL7014559 | 0.88 | POLB (0.47) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL12977996 | 0.88 | TPMT (0.44) | TPMTCA5ACA12CA1CA2 | |
| SCHEMBL12666031 | 0.88 | TPMT (0.50) | TPMTCA5ACA12CA1CA2 | |
| Acetic Acid SCHEMBL27736877 | 0.88 | TPMT (0.60) | TPMTCA5ACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115869785-B | Ultrafast preparation method of graphite alkyne composite membrane | 北京化工大学 | 2024-11-26 | — | — | CN | claimed |
| EP-3129526-B1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-08-07 | — | — | EP | claimed |
| CN-106460182-B | The method of bath compositions and the electroless for palladium | 安美特德国有限公司 | 2019-07-09 | — | — | CN | claimed |
| US-9758874-B2 | Plating bath composition and method for electroless plating of palladium | ATOTECH DEUTSCHLAND GMBH (DE) | 2017-09-12 | — | — | US | claimed |
| US-20170121823-A1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2017-05-04 | — | — | US | claimed |
| CN-106460182-A | Plating bath composition and method for electroless plating of palladium | 安美特德国有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-119318887-A | Graphite alkyne multilayer composite membrane and preparation method thereof | 北京化工大学 | 2025-01-17 | — | — | CN | disclosed |
| CN-115869785-B | Ultrafast preparation method of graphite alkyne composite membrane | 北京化工大学 | 2024-11-26 | — | — | CN | disclosed |
| US-11713338-B2 | Cyclic peptides multimers targeting α-4-β-7 integrin | ZEALAND PHARMA A/S (DK) | 2023-08-01 | — | — | US | disclosed |
| US-11713338-B2 | Cyclic peptides multimers targeting α-4-β-7 integrin | ZEALAND PHARMA A/S (DK) | 2023-08-01 | — | — | US | disclosed |
| CN-108780275-B | Photosensitive film | 东丽株式会社 | 2022-11-08 | — | — | CN | disclosed |
| CN-113527101-A | Novel compound, polymer and method for producing same, photosensitive resin composition, method for forming pattern, cured film, and electronic component | 信越化学工业株式会社 | 2021-10-22 | — | — | CN | disclosed |
| CN-113527680-A | Polymer, photosensitive resin composition, pattern forming method, cured film, and electronic component | 信越化学工业株式会社 | 2021-10-22 | — | — | CN | disclosed |
| US-20090159527-A1 | MODIFIED MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC | 2009-06-25 | — | — | US | disclosed |
| US-7498436-B2 | Substituted hydroxyethylamines | PHARMACIA & UPJOHN COMPANY LLC (US) | 2009-03-03 | — | — | US | disclosed |
| US-20080096942-A1 | Substituted Hydroxyethylamines | ELAN PHARMACEUTICALS, INC. | 2008-04-24 | — | — | US | disclosed |
| US-7312360-B2 | Substituted hydroxyethylamines | ELAN PHARMACEUTICALS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| US-20070213407-A1 | Compounds to treat Alzheimer's disease | ELAN PHARMACEUTICALS AND PHARMACIA & UPJOHN COMPANY LLC | 2007-09-13 | — | — | US | disclosed |
| US-5362843-A | Phenyl branching agents | HOECHST CELANESE CORPORATION (US) | 1994-11-08 | — | — | US | disclosed |
| US-3995044-A | Pyridine carboxylic acid amides for mycobacterium infections | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096942-A1 | Substituted Hydroxyethylamines | BACE1, BACE2, MME | TPMT 962/4885CA5A 3619/4885CA12 4140/4885 |
| US-20070213407-A1 | Compounds to treat Alzheimer's disease | PSEN2, PSEN1, CHAT | TPMT 779/4885CA5A 953/4885CA12 1162/4885 |
| US-11713338-B2 | Cyclic peptides multimers targeting α-4-β-7 integrin | ITGB7, ITGB4, ITGA4 | TPMT 4701/4885CA5A 4045/4885CA12 1812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.